3 reasons 2026 is the year of solid tumor immunotherapy success

добавлена новая статья Health

2026-01-19 13:22:22 -

As 2026 progresses, the long-standing barrier to treating solid tumors with immune-based therapies is finally crumbling. While blood cancers have seen significant success over the last decade, breast, colon, and prostate cancers have historically been protected by a "cold" tumor microenvironment that repels T-cells. However, new data from major oncology conferences in the first half of 2026...

0 Комментарии 0 Поделились 8 Просмотры 0 предпросмотр